Potassium Citrate
NDC 70518-3160, Potassium Citrate, tablet, extended release, from REMEDYREPACK INC..
- Product NDC
- 70518-3160
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212779
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CITRATE10 meq/1
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-3160-0 | 70518316000 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3160-0) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a9cc636d-3e26-450c-9df8-665d530d626f
Use it
Look up 70518-3160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-3160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.